Acinetobacter baumannii

Transcriptome analysis of Acinetobacter baumannii cells under different conditions

OmicsBox Supported Project. Researchers: Shruti Kashyap Investigators: Dr. Neena Capalash and Dr. Prince Sharma Background and Project Overview: A.baumannii, a nosocomial pathogen, ranks first in the WHO’s list of antibiotic-resistant priority pathogen. The problem of increasing frequency of multi-drug resistance in A. baumannii has been further compounded by tolerance to high concentration of antibiotics due to persister cells. Persister cells

Read More »

BioBam Student Scholarship – Apply Now!

We are happy to announce that during the next 6 month, starting on the 1st of July, we will grant a full-featured 6-month OmicsBox subscription to 5 selected student projects – each month! Please submit before the 15th of each month to participate. Please send us a short description (200 words max.) of your research project including planned bioinformatics work and

Read More »

Lipid transcriptome profiling of indigenous Dunaliella sp. isolate

BioBam Bioinformatics S.L. Supported Project. Researchers: Nahid Hosseinzadeh Gharajeh Mohammad Amin Hejazi Mostafa Valizadeh Ebrahim Dorani Background and Project Overview: Dunaliella is a unicellular, halotolerant, biflagellate microalga which is already exploited as a platform in food, feed, aquaculture, biomedical, pharmaceutical, nutraceutical and cosmeceutical industries, specifically due to its high production of β-carotene and fine chemicals. There is a wide range

Read More »

Interview with Mariana Monteiro

Interview with Mariana Monteiro, Sales and Customer Manager at BioBam. What I value the most about BioBam is that it is a very human company very close to its employees.

Read More »

Blog Categories:

News

Releases, Media, Announcements, etc.

Tips And Tricks

Mini-tutorials for common use-cases and to address frequently asked questions FAQs

Video Tutorials

Helpful Features, Tips and Tricks

Use Cases, Reviews, Tutorials

Product Tutorial, Quickstarts, New Features, etc.

Most Popular: